Precision Oncology Market Insights 2025-2034: Growth Forecast and Strategic Priorities

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Precision Oncology Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, there has been a noticeable expansion in the size of the precision oncology market. The market is projected to increase from $95.73 billion in 2024 to $106.21 billion in 2025, which corresponds to a compound annual growth rate (CAGR) of 11.0%. The surge in size during the historic period is a result of numerous factors. These include a rise in the approval of companion diagnostics, a greater emphasis on biomarker discovery and validation, an increase in investment in oncology research and innovation, growth in the number of clinical trials related to precision oncology, and a growing preference for diagnostic techniques that involve minimal invasion.

Precision Oncology Market Size Forecast: What's the Projected Valuation by 2029?
The market size for precision oncology is anticipated to experience accelerated expansion in the coming years, with a prediction to reach $158.90 billion by 2029 by growing at a compound annual growth rate (CAGR) of 10.6%. The surge in growth during the forecast period is linked to an increase in cancer instances, greater usage of diagnostics based on genomics, increased knowledge among patients and doctors, increased use of next-generation sequencing and the increased demand for cancer treatments targeted at specific conditions. The forecast period is set to see significant trends including advancements in liquid biopsy technologies, enhanced use of single-cell sequencing in tumor analysis, the growth of decentralized testing platforms, advancements in radio genomics for treatment planning, and the progress in cancer vaccines customised for individual patients.

View the full report here:
https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

What Are the Drivers Transforming the Precision Oncology Market?
The precision oncology market is anticipated to witness significant growth, driven by the rising cognizance and the increasing transition towards personalized therapies. Personalized therapies are uniquely tailored based on an individual's genetic makeup, biomarkers, and distinct disease characteristics to augment effectiveness and minimize side effects. These therapies are gaining prominence through advancements in genomic technologies that facilitate the accurate detection of disease-specific mutations, thus promoting more efficient and targeted treatments. Precision oncology plays a crucial role in enhancing personalized therapies by leveraging genomic and molecular profiling to adapt cancer treatment to the specific genetic constitution of a patient's tumor. For instance, the Health and Social Care Secretary of a UK-based government department, according to GOV.UK, entered into an MoU with BioNTech SE in February 2023 to propel cancer vaccine research in England, aiming to provide 10,000 personalized therapy doses to UK patients by 2030. Hence, the growing awareness and migration towards personalized therapies stimulate the development of the precision oncology market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

Which Emerging Trends Are Transforming the Precision Oncology Market in 2025?
Leading corporations within the precision oncology market are concentrating on the creation of novel methods such as the molecular tumor board. This is an attempt to bolster personalized treatment choices by incorporating genomic data within a clinical context. A molecular tumor board constitutes a dedicated group of experts responsible for the analysis and interpretation of complicated genomic and molecular testing data. This information is then utilized to guide precision-based cancer treatments that are specifically catered to the distinct tumor traits of individual patients. For example, in December 2024, Aster DM Healthcare Ltd., a UAE healthcare service provider, rolled out a precision oncology clinic. This is part of the three bespoke cancer care initiatives aimed at revolutionizing treatment via data-centric, genome-focused approaches. The clinic offers tailor-made cancer treatment grounded in each patient's tumor genetic profile, which facilitates more accurate and effective treatments that have fewer side effects. This strategy not only enhances treatment results and reduces toxicity, but also boosts the quality of life by matching treatments with the patient's specific cancer molecular attributes.

Which Segments in the Precision Oncology Market Offer the Most Profit Potential?
The precision oncology market covered in this report is segmented

1) By Type: Genomic Sequencing, Immunotherapy
2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics
3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers
4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy
5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:
1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing
2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Which Firms Dominate the Precision Oncology Market by Market Share and Revenue in 2025?
Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Which Regions Offer the Highest Growth Potential in the Precision Oncology Market?
North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27395

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.